High Oxygen Delivery to Preserve Exercise Capacity in Idiopathic Pulmonary Fibrosis Patients Treated With Nintedanib
High Oxygen Delivery to Preserve Exercise Capacity in IPF Patients Treated With Nintedanib: The HOPE-IPF Study
University of British Columbia
88 participants
Dec 1, 2015
INTERVENTIONAL
Conditions
Summary
The purpose is to determine if patients with idiopathic pulmonary fibrosis (IPF) taking nintedanib will have improved exercise endurance, breathlessness and quality of life if breathing 60% oxygen compared to standard of care during an 8 week exercise training program.
Eligibility
Inclusion Criteria7
- Age 19 years or older
- Idiopathic Pulmonary Fibrosis (IPF) diagnosis according to American Thoracic Society and/or European Respiratory Society consensus criteria
- Appropriate candidate for pulmonary rehabilitation
- prescribed nintedanib by their treating physician or currently on nintedanib
- minute walk distance 50m or more
- Oxygen saturation 92% or more by pulse oximetry at rest while breathing room air
- Clinically stable for the preceding 6 weeks
Exclusion Criteria8
- Contraindication to treatment with nintedanib (based on Canadian labeling)
- Contraindication to exercise testing (e.g. significant cardiovascular, musculoskeletal, neurological disease)
- Other significant extra-pulmonary disease that, based on clinical assessment, could impair exercise capacity and/or oxygenation
- Forced vital capacity (FVC) less than 50% or Diffusion capacity for carbon monoxide (DLCO) less than 25%
- Concurrent or recent participation (less than 6 months) in a pulmonary rehabilitation program
- Use of prednisone greater than 10 mg/day for more than 2 weeks within 3 months of the first study visit
- Use of pirfenidone within 4 weeks of screening
- Significant emphysema (less than 10% volume on high resolution computed tomography (HRCT) or forced expiratory volume at one second (FEV1)/FVC less than 0.70)
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
While participants are exercising, they will be inhaling 60% oxygen through a mask
While participants are exercising, they will be breathing air through a mask that will be titrated to keep oxygen saturation at least 88%, allowing a maximum inhaled oxygen percentage of 40%.
Locations(8)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT02551068